Facial Skin Cancer Research Articles

What do Patients say About Facial Skin Cancer Surgery? Analysis of Aspects of Quality Using a New Tool to Measure Patient Reported Experience and Outcome in the Surgical Management of Non-Melanoma Skin Cancer of the Head and Neck (NMSC)

What do Patients say About Facial Skin Cancer Surgery? Analysis of Aspects of Quality Using a New Tool to Measure Patient Reported Experience and Outcome in the Surgical Management of Non-Melanoma Skin Cancer of the Head and Neck (NMSC)

Analysis of First Case Series in the World of Skin Cancer Patients Where Lead Shielding for Radiation Therapy of Facial Skin Cancer was Designed Utilizing Optical Scanner and 3D Printer Technology

Analysis of First Case Series in the World of Skin Cancer Patients Where Lead Shielding for Radiation Therapy of Facial Skin Cancer was Designed Utilizing Optical Scanner and 3D Printer Technology

UK-based prospective cohort study to anglicise and validate the FACE-Q Skin Cancer Module in patients with facial skin cancer undergoing surgical reconstruction: the PROMISCR (Patient-Reported Outcome Measure in Skin Cancer Reconstruction) study

IntroductionSkin cancer is the most common malignancy worldwide, often occurring on the face, where the cosmetic outcome of treatment is paramount. A number of skin cancer-specific patient-reported outcome measures (PROMs)...

Skin cancers of the face in an African Black population

Introduction: The aim of this study was to evaluate the frequency and clinico-anatomical features of facial skin cancers in an African Black population.

Application of Mohs Surgery to the Treatment of Basosquamous Cell Carcinoma Originating from the Auricle

Complete removal is most important in treating the malignant tumor from the auricle, but the cosmetic and reconstructive plan after removal should also be considered because auricular appearance contributes enormously to the facial aesthetics. Mohs micrographic surgery (MMS), which is commonly used in dermatology, is considered as minimal marginal surgery that offers superior cure rates in the treatment of facial skin cancer. Therefore, MMS could provide a minimally invasive way to manage the malignant tumor of the auricle. This article reports that basosquamous cell carcinoma arising in the auricle was treated with wide resection combined with MMS. Conclusively, we could accomplish the surgical purpose of both completely removing the tumor and maintaining the auricular aesthetic shape by additionally introducing MMS in the treatment. Key words: Auricle ㆍ Basosquamous cell carcinoma ㆍ Mohs’surgery

Safety of Local Intracutaneous Lidocaine Anesthesia Used by Dermatologic Surgeons for Skin Cancer Excision and Postcancer Reconstruction: Quantification of Standard Injection Volumes and Adverse Event Rates.

Intracutaneous lidocaine is used for anesthesia in dermatologic surgery for skin cancer excision and repair with exceedingly low incidence of reported adverse events. To measure (1) the quantity of lidocaine typically used for facial skin cancer excision and reconstruction; and (2) the frequency and character of associated adverse events. Survey study of dermatologic surgeons with longitudinal reporting. Reported practice during 10 business days: (1) mean volume of 1% lidocaine per skin cancer excision; (2) maximum per excision; (3) mean per reconstruction; and (4) maximum per reconstruction. A total of 437 of 1,175 subjects contacted (37.2%) responded. Mean per excision was 3.44 mL (SD: 2.97), and reconstruction 11.70 mL (10.14). Maximum per excision was 6.54 mL (4.23), and reconstruction was 15.85 mL (10.39). No cases of lidocaine toxicity were reported, diagnosed, or treated. Incidence of adverse events possibly anesthesia related was >0.15%, with most (0.13%) being mild cases of dizziness, drowsiness, or lightheadedness from epinephrine tachycardia. Toxicity associated with local anesthesia other than lidocaine was not studied. Volumes of lidocaine in skin cancer excision and repair are modest and within safe limits. Lidocaine toxicity is exceedingly rare to entirely absent. For comparable indications, lidocaine is safer than conscious sedation or general anesthesia.

Using Optical Scanner and 3-Dimensional Printer Technology to Create Lead Shielding for Radiation Therapy of Facial Skin Cancer With Low-Energy Photons: An Exciting Innovation

Using Optical Scanner and 3-Dimensional Printer Technology to Create Lead Shielding for Radiation Therapy of Facial Skin Cancer With Low-Energy Photons: An Exciting Innovation

86: Using Optical Scanner and 3D Printer Technology to Create Lead Shielding for Radiotherapy of Facial Skin Cancer with Low Energy Photons: An Exciting Innovation

86: Using Optical Scanner and 3D Printer Technology to Create Lead Shielding for Radiotherapy of Facial Skin Cancer with Low Energy Photons: An Exciting Innovation

Poster – 39: Using Optical Scanner and 3D Printer Technology to Create Lead Shielding for Radiotherapy of Facial Skin Cancer with Low Energy Photons

Purpose:Treatment of skin cancers of the face using orthovoltage radiotherapy often requires lead shielding. However, creating a lead shield can be difficult because the face has complex and intricate contours. The traditional process involved creating a plaster mould of the patient's face can be difficult for patients. Our goal was to develop an improved process by using an optical scanner and 3D printer technology.Methods:The oncologist defined the treatment field by drawing on each patient's skin. Three‐dimensional images were acquired using a consumer‐grade optical scanner. A 3D model of each patient's face was processed with mesh editing software before being printed on a 3D printer. Using a hammer, a 3 mm thick layer of lead was formed to closely fit the contours of the model. A hole was then cut out to define the field.Results:The lead shields created were remarkably accurate and fit the contours of the patients. The hole defining the field exposed only a minimally sized site to be exposed to radiation, while the rest of the face was protected. It was easy to obtain perfect symmetry for the definition of parallel opposed beams.Conclusion:We are routinely using this technique to build lead shielding that wraps around the patient as an alternative to cut‐outs. We also use it for treatment of the tip of the nose using a parallel opposed pair beams with a wax nose block. We found this technique allows more accurate delineation of the cut‐out and a more reproducible set‐up.

Patients more Likely to Prefer Surgery to Novel Photodynamic Therapy

Objective: To compare preferences with patients who have undergone both facial skin cancer surgery and photodynamic therapy (PDT). Design: A survey of patients who had undergone both PDT and surgery to their face. Setting: Referral skin cancer centre in Australia Protocol: 34 patients had undergone both PDT and surgery to their face. They were asked which they would choose next time if given both options and why. Main outcome measure(s): Patient preference of the two treatments Results: Of the 34 PDT patients, 17 preferred surgery if future treatment was needed, whilst 6 preferred PDT, (p<0.01). Prolonged post procedural pain was the most frequent explanation provided for preferring surgery. Discussion and conclusions: Clinicians should not assume that surgery is less favoured by patients over alternate interventions. Prolonged pain following PDT was a frequent reason not to prefer future PDT treatments.

Audit of all surgically treated non-melanomatous facial skin cancers in a single Maxillofacial Unit, 2006 to 2014

Audit of all surgically treated non-melanomatous facial skin cancers in a single Maxillofacial Unit, 2006 to 2014

A Retrospective Review of Reconstructive Options and Outcomes of 202 Cases Large Facial Mohs Micrographic Surgical Defects, Based on the Aesthetic Unit Involved.

For optimal treatment of facial defects following Mohs micrographic surgery (MMS), the aesthetic unit principles should be applied. Often multiple staged procedures and revisions are necessary. To analyze the reconstructive options and outcomes for complex facial defects per aesthetic unit. Data of 202 patients, who underwent a facial reconstruction at the department of plastic and reconstructive surgery following MMS, were collected. The central facial units were affected in more than 70%, with over 20% of the defects involving more than 1 unit. Nasal defects required the longest reconstruction time (3-staged forehead flap) and periocular defects the most revisional procedures. In more than 50%, additional operations (range, 1-5) were needed. In 12%, postoperative complications occurred. An overview for the reconstructive options of extensive facial skin cancer is presented. Proper treatment requires a structured multidisciplinary approach in order to achieve excellent tumour control and a satisfactory aesthetic and functional end result.

Surgical treatment and reconstruction of nonmelanoma facial skin cancers.

After reading this article, the participant should be able to: (1) Identify the appropriate resection margins for common types of nonmelanoma skin cancer. (2) Discuss indications for secondary intention healing, skin grafting, and local flaps for reconstruction of facial skin cancer defects. (3) Describe at least one local flap for reconstruction of scalp, forehead, temple/cheek, periocular, nose, and lips. Current evidence for diagnosis and surgical treatment of nonmelanoma facial skin cancers is reviewed. In addition, reconstructive options for facial defects are discussed by anatomic location.

Patient experiences and outcomes following facial skin cancer surgery: A qualitative study.

Early melanoma and non-melanoma skin cancer of the facial area are primarily treated with surgery. Little is known about the outcomes of treatment for facial skin cancer patients. The objective of the study was to identify concerns about aesthetics, procedures and health from the patients' perspective after facial skin surgery. Semi-structured in-depth interviews were conducted with 15 participants. Line-by-line coding was used to establish categories and develop themes. We identified five major themes on the impact of skin cancer surgery: appearance-related concerns; psychological (e.g., fear of new cancers or recurrence); social (e.g. impact on social activities and interaction); physical (e.g. pain and swelling) concerns and satisfaction with the experience of care (e.g., satisfaction with surgeon). The priority of participants was the removal of the facial skin cancer, as this reduced their overall worry. The aesthetic outcome was secondary but important, as it had important implications on the participants' social and psychological functioning. The participants' experience with the care provided by the surgeon and staff also contributed to their satisfaction with their treatment. This conceptual framework provides the basis for the development of a new patient-reported outcome instrument.

PO-1053: Primary facial skin cancer and skin metastatic breast cancer successfuly treated with HDR plesiotherapy

PO-1053: Primary facial skin cancer and skin metastatic breast cancer successfuly treated with HDR plesiotherapy

Local Flap Surgical Scar Management Caused by Skin Cancer Using Fractional CO2Laser Treatment

Background Despite careful and atraumatic surgical techniques, surgical treatment and reconstruction can result in scarring. Scar from skin cancer on the face may continue for a long time. This current report demonstrates the utility of a fractional CO2 laser to treat facial scar resulting from local flap coverage to remove skin cancer. Methods Five patients underwent local flap coverage after removing facial skin cancer tumors. The resulting scars after reconstruction of these skin cancer defects are on face. Each received 6 treatments with a fractional CO2 laser device (LineXel ® ; UTI Co. Ltd, Seoul, Korea). Treatments were spaced about 1 month apart. Results were evaluated before the initial treatment, and at 1 month after the last treatment session. Results The fractional CO2 laser device is effective for treating surgical scars especially on scar texture and thickness without significant adverse effects. Prior to the laser session, these scars concerned different pigmentation, pliability, height, vascularity compared to the surrounding skin. Patients also expressed a 4-point subjective scale of satisfaction. Patients were satisfied with the treated scars. Conclusions The fractional CO2 laser device of the present report is an effective treatment modality for facial scars after reconstruction of skin cancer defects. Besides this laser also does not show any serious adverse effect

Benefits of a Shared Training Programme for the Management of Cutaneous Cancer of the Head and Neck

Removal of facial skin skin cancers and subsequent reconstruction are core skills in the curriculum for higher specialist training in Oral and Maxillofacial surgery (OMFS).1 The patients seen tend to have difficult tumours and the training places a heavy emphasis on surgical technique. Some OMFS trainees go on to work in hospitals where they have a bigger role in the skin cancer service.

See-and-treat surgery for facial skin cancer

See-and-treat surgery has been described as an efficient means of streamlining specialist diagnosis and treatment, and is commonly employed in gynaecology to reduce the delay between cytological screening and definitive treatment of cervical neoplasia. Relatively young patients with predominantly benign skin lesions have been treated in see-and-treat clinics but only in the context of referrals from primary care. The author describes the treatment of tertiary referrals for facial skin malignancies under local anaesthesia at these clinics, and analyses their acceptability to patients. A total of 100 consecutive patients were included. Data on age, coexisting conditions, diagnosis, site and size of lesion, operation, and outcomes including complications and completeness of excision, were collected. A questionnaire seeking patients’ opinions was also used. Ninety patients were treated and 98 lesions were removed, 94% of which were malignant. The complete excision rate was 95%. There were no complications, and 98% of patients were satisfied with the service. See-and-treat surgery is an effective, safe, and acceptable means of providing surgical management of facial skin malignancies.

A guide to skin cancer of the face for the dental team.

The incidence of skin cancer in the United Kingdom is increasing and is associated with an ageing population and increasing lifetime exposure to sunlight. The three most common types of skin cancer are basal cell carcinoma, squamous cell carcinoma and malignant melanoma, all three of which may present on the skin of the face. The dental team are, therefore, well-placed to recognize suspicious lesions and arrange for further advice or assessment. This paper outlines the epidemiology, important clinical features and principles of modern management of facial skin cancers to aid dental practitioners in the recognition of suspicious lesions. In addition, some of these treatments have side-effects which have the potential to affect a patient's oral health or its management and these aspects are also discussed. The dental surgeon is ideally placed to recognize malignant or potentially malignant lesions on patients'faces and to advise on seeking further advice or refer for assessment, as appropriate. Dental practitioners will increasingly encounter patients who have undergone surgical or non-surgical management of facial skin cancer and should understand the potential oro-facial side-effects of such treatment.

The role of rehabilitative camouflage after cervicofacial reconstructive surgery: a preliminary study

A randomized, prospective, controlled study was carried out at the Plastic and Reconstructive Surgery Unit of the University of Pavia, Salvatore Maugeri Research and Care Institute, Pavia, Italy, to evaluate the psychological benefits from corrective medical camouflage (CMC) following surgical treatment for skin cancer of the face. Twenty-four female patients, following recovery from facial skin cancer surgery, were enrolled in the study over a period of 1 year. The study was performed using two health-related quality of life tests, the Satisfaction Profile (SAT-P) test and the Body Uneasiness Test (BUT). The patients were randomized into two groups: group A, patients undergoing CMC; and group B, controls. Both the SAT-P and BUT demonstrated statistically significant better results in the treated patients versus the controls in the following functional parameters: Psychological Functionality (PsF), Physical Functionality (PhF), and Work Performance (WP) for the SAT-P test and Compulsive Self-Monitoring (CSM) for the BUT. The PsF demonstrated a better result 6 months post-treatment. Such a difference was particularly significant when comparing the performance at 6 months versus that at 3 months. The PhF demonstrated a better outcome at 6 months post-treatment. The WP demonstrated a better result comparing the performance at 6 months versus that at 3 months. The CSM demonstrated a better outcome at 6 months post-treatment. The CMC promoted a significant improvement in patients’ physical appearance and in their self-image and perceived social role as a means of their desire to disguise their body disfiguration.